Charles River initially unveiled a plan to adopt new alternative methods (NAMs), like computer models and human organoids, in ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

GemPharmatech, a global leader in genetically engineered mouse models and preclinical contract research services, today ...

Pfizer sold the five-building facility on Science Center Drive in Torrey Pines to BioMed Realty, a San Diego-based firm owned ...

SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor ...

It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.

Pfizer is officially bidding adieu to its sprawling research site in San Diego as it readjusts its local footprint and moves into a new site. | The company is moving its oncology R&D digs in San Diego ...

Anduril Industries is leasing a large chunk of local warehouse space less than a mile from its Costa Mesa headquarters, ...

Robles BioCeutics, a regenerative dermatology biotechnology company pioneering next-generation skincare solutions using stem cell and senolytics technologies, is pleased to welcome Dr. Radu Pislariu ...

SAN DIEGO (FOX 5/KUSI) — Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its ...

today announced the grand opening of its newly expanded U.S. headquarters in San Diego's premier biotech corridor, marking a significant milestone in the company's North American expansion strategy.